Become a Premium member to Download. If you are already a Premium member, Login here to access.
PRINCETON - PDS Biotechnology Corporation (NASDAQ:PDSB) has confirmed plans to commence its VERSATILE-003 Phase 3 clinical trial for a promising cancer immunotherapy within the first quarter of 2025.
Tech Xplore on MSN10h
Porous plastic sheets can cool buildings by radiating light to spaceTraditional cooling systems for buildings use refrigerants and electricity, which contribute to the atmospheric greenhouse ...
Tech Xplore on MSN8h
Scientists enhance high-resolution distributed temperature sensing using plastic optical fibersScientists have developed a new approach to significantly enhance the spatial resolution of distributed temperature sensing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback